Ningbo Lian Technology Co.,Ltd (SHE:300784)

Market Cap	3.02B
Revenue (ttm)	515.02M
Net Income (ttm)	62.50M
Shares Out	56.24M
EPS (ttm)	1.19
PE Ratio	45.24
Forward PE	n/a
Dividend	0.40 (0.75%)
Ex-Dividend Date	May 20, 2025

Volume	482,000
Average Volume	792,919
Open	54.70
Previous Close	53.42
Day's Range	53.40 - 54.70
52-Week Range	41.00 - 76.40
Beta	n/a
RSI	49.66
Earnings Date	Aug 23, 2025

About Ligand Pharmaceuticals

Ningbo Lian Technology Co.,Ltd engages in the research and development, production, and sale of precision injection molds and injection products for enterprises and listed companies in China and internationally. The company’s injection molding products are mainly used in consumer electronics, toys, daily necessities, auto parts, and medical equipment. It also produces precision injection molds; and purchases and sells non-injection toy products, such as dominoes. The company was founded in 2006 and is based in Ningbo, China.

• Industry: Industrial - Machinery
• Sector: Industrials
• Founded: 2006
• Employees: 1,388
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300784

Financial Performance

In 2024, SHE:300784's revenue was 511.80 million, an increase of 9.01% compared to the previous year's 469.48 million. Earnings were 65.81 million, a decrease of -13.07%.